返回 Agenda
Special Discussion
Session Chair(s)
Tatsuo Kurokawa, DIAFellow, PhD
Director General
The Japan Biosimilar Association, Japan
In this session, panelists who have led regulatory science as top leaders in the US and Japan will discuss past regulatory collaborations and their future visions, introducing their thoughts about regulatory science, what activities they have done before, and what they would like to do in the future, and consider the promotion of higher-quality regulatory science among the audience from industry and academia.
Speaker(s)
Margaret A. Hamburg, MD
NTI | bio Advisory Group, United States
Interim Vice President, Global Biological Policy and Programs; Chair
Tatsuya Kondo, MD, PhD
SH Medical Excellence JAPAN, Japan
President